Literature DB >> 33817785

Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects.

Mariana Rae1,2, Mariana Lemos Duarte2, Ivone Gomes2, Rosana Camarini1, Lakshmi A Devi2.   

Abstract

Oxytocin (OT) and vasopressin (AVP) are endogenous ligands for OT and AVP receptors in the brain and in the peripheral system. Several studies demonstrate that OT and AVP have opposite roles in modulating stress, anxiety and social behaviours. Interestingly, both peptides and their receptors exhibit high sequence homology which could account for the biased signalling interaction of the peptides with OT and AVP receptors. However, how and under which conditions this crosstalk occurs in vivo remains unclear. In this review we shed light on the complexity of the roles of OT and AVP, by focusing on their signalling and behavioural differences and exploring the crosstalk between the receptor systems. Moreover, we discuss the potential of OT and AVP receptors as therapeutic targets to treat human disorders, such as autism, schizophrenia and drug abuse. LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.8/issuetoc.
© 2021 The British Pharmacological Society.

Entities:  

Keywords:  GPCR; anxiety; crosstalk; oxytocin; social behaviour; substance use disorder; vasopressin

Mesh:

Substances:

Year:  2021        PMID: 33817785      PMCID: PMC8488062          DOI: 10.1111/bph.15481

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   9.473


  148 in total

1.  Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats.

Authors:  R J Windle; N Shanks; S L Lightman; C D Ingram
Journal:  Endocrinology       Date:  1997-07       Impact factor: 4.736

2.  Oxytocin Reduces Cigarette Consumption in Daily Smokers.

Authors:  Kathryne Van Hedger; Meredith J Kushner; Royce Lee; Harriet de Wit
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

3.  A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.

Authors:  Federico Bolognani; Marta Del Valle Rubido; Lisa Squassante; Christoph Wandel; Michael Derks; Lorraine Murtagh; Jeff Sevigny; Omar Khwaja; Daniel Umbricht; Paulo Fontoura
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

4.  Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder.

Authors:  Jennifer M Mitchell; Peter A Arcuni; Dawn Weinstein; Josh D Woolley
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

Review 5.  Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.

Authors:  Inga D Neumann; Rainer Landgraf
Journal:  Trends Neurosci       Date:  2012-09-11       Impact factor: 13.837

Review 6.  Social effects of oxytocin in humans: context and person matter.

Authors:  Jennifer A Bartz; Jamil Zaki; Niall Bolger; Kevin N Ochsner
Journal:  Trends Cogn Sci       Date:  2011-06-21       Impact factor: 20.229

Review 7.  Neuromodulation by oxytocin and vasopressin.

Authors:  Ron Stoop
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 8.  Vasopressin: behavioral roles of an "original" neuropeptide.

Authors:  Heather K Caldwell; Heon-Jin Lee; Abbe H Macbeth; W Scott Young
Journal:  Prog Neurobiol       Date:  2007-11-04       Impact factor: 11.685

9.  Vasopressin and ethanol preference. I. Effects of vasopressin and the fragment DGAVP on altered ethanol preference in Brattleboro diabetes insipidus rats.

Authors:  H Rigter; J C Crabbe
Journal:  Peptides       Date:  1985 Jul-Aug       Impact factor: 3.750

10.  The vagus nerve mediates the suppressing effects of peripherally administered oxytocin on methamphetamine self-administration and seeking in rats.

Authors:  Nicholas A Everett; Anita J Turner; Priscila A Costa; Sarah J Baracz; Jennifer L Cornish
Journal:  Neuropsychopharmacology       Date:  2020-05-25       Impact factor: 7.853

View more
  6 in total

Review 1.  Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities.

Authors:  Nicole Rigney; Geert J de Vries; Aras Petrulis; Larry J Young
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

Review 2.  Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis.

Authors:  Syed Faizan Mehdi; Suma Pusapati; Raja Ram Khenhrani; Muhammad Saad Farooqi; Sobia Sarwar; Ahmad Alnasarat; Nimisha Mathur; Christine Noel Metz; Derek LeRoith; Kevin J Tracey; Huan Yang; Michael J Brownstein; Jesse Roth
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

3.  Vasopressin but Not Oxytocin Responds to Birth Stress in Infants.

Authors:  Sara Fill Malfertheiner; Evelyn Bataiosu-Zimmer; Holger Michel; Sotirios Fouzas; Luca Bernasconi; Christoph Bührer; Sven Wellmann
Journal:  Front Neurosci       Date:  2021-08-27       Impact factor: 4.677

Review 4.  Effects of Intranasal Administration of Oxytocin and Vasopressin on Social Cognition and Potential Routes and Mechanisms of Action.

Authors:  Shuxia Yao; Keith Maurice Kendrick
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

5.  Differential fate between oxytocin and vasopressin cells in the developing mouse brain.

Authors:  Amelie Soumier; Marie Habart; Guillaume Lio; Caroline Demily; Angela Sirigu
Journal:  iScience       Date:  2021-12-18

6.  Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin.

Authors:  Friederike Holze; Isidora Avedisian; Nimmy Varghese; Anne Eckert; Matthias E Liechti
Journal:  Front Pharmacol       Date:  2021-07-13       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.